Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study

Detalles Bibliográficos
Autores principales: Lytvyn, Yuliya, Mufti, Asfandyar, Zaaroura, Hiba, Sachdeva, Muskaan, Lu, Justin D., Rankin, Brian D., Prajapati, Vimal H., Vender, Ronald, Yeung, Jensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592884/
https://www.ncbi.nlm.nih.gov/pubmed/34816136
http://dx.doi.org/10.1016/j.jdin.2021.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592884/
https://www.ncbi.nlm.nih.gov/pubmed/34816136
http://dx.doi.org/10.1016/j.jdin.2021.09.007

Ejemplares similares